BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res. 1992;7:501-512. [PMID: 1615759 DOI: 10.1002/jbmr.5650070506] [Cited by in Crossref: 167] [Cited by in F6Publishing: 166] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer. 2002;95:267-274. [PMID: 12124825 DOI: 10.1002/cncr.10644] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 4.6] [Reference Citation Analysis]
2 Czekanska EM, Stoddart MJ, Ralphs JR, Richards RG, Hayes JS. A phenotypic comparison of osteoblast cell lines versus human primary osteoblasts for biomaterials testing. J Biomed Mater Res A 2014;102:2636-43. [PMID: 23983015 DOI: 10.1002/jbm.a.34937] [Cited by in Crossref: 118] [Cited by in F6Publishing: 104] [Article Influence: 13.1] [Reference Citation Analysis]
3 Manuel Quesada J, Alonso J, Gonzalez J, Muñoz R, Jans I, Martiu A, Bouillon R. Serum β-2 microglobulin is a marker of high bone remodelling in elderly women. Mechanisms of Ageing and Development 1998;102:293-8. [DOI: 10.1016/s0047-6374(98)00019-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Siggelkow H, Niedhart C, Kurre W, Ihbe A, Schulz A, Atkinson MJ, Hüfner M. In vitro differentiation potential of a new human osteosarcoma cell line (HOS 58). Differentiation 1998;63:81-91. [DOI: 10.1046/j.1432-0436.1998.6320081.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
5 Kazakova MH, Batalov AZ, Mateva NG, Kolarov ZG, Sarafian VS. YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis? Folia Med (Plovdiv) 2017;59:37-42. [PMID: 28384116 DOI: 10.1515/folmed-2017-0013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
6 Rico H, Ripoll E, Arribas I, Revilla M, Relea P, Villa LF, de Buergo Alvarez M. β2-microglobulin in Paget's bone disease. Calcif Tissue Int 1994;54:389-91. [DOI: 10.1007/bf00305525] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
7 Bollen A, Eyre DR. Direct extraction of gelatinases from rat bone. Connective Tissue Research 2009;29:223-30. [DOI: 10.3109/03008209309016829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Shao R, Taylor SL, Oh DS, Schwartz LM. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget 2015;6:40507-18. [PMID: 26439689 DOI: 10.18632/oncotarget.5943] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
9 Roslind A, Balslev E, Kruse H, Stærgaard B, Horn T. Subcellular Localization of YKL-40 in Normal and Malignant Epithelial Cells of the Breast. Ultrastructural Pathology 2009;32:101-6. [DOI: 10.1080/01913120801937673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Dehn H, Høgdall EVS, Johansen JS, Jørgensen M, Price PA, Engelholm SAA, Høgdall CK. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer: YKL-40 and ovarian cancer. Acta Obstetricia et Gynecologica Scandinavica 2003;82:287-93. [DOI: 10.1034/j.1600-0412.2003.00010.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
11 Johansen JS, Møller S, Price PA, Bendtsen F, Junge J, Garbarsch C, Henriksen JH. Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol. 1997;32:582-590. [PMID: 9200292 DOI: 10.3109/00365529709025104] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 3.2] [Reference Citation Analysis]
12 De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285:926-931. [PMID: 11467840 DOI: 10.1006/bbrc.2001.5253] [Cited by in Crossref: 125] [Cited by in F6Publishing: 125] [Article Influence: 6.0] [Reference Citation Analysis]
13 Naglot S, Aggarwal P, Dey S, Dalal K. Estimation of Serum YKL-40 by Real-Time Surface Plasmon Resonance Technology in North-Indian Asthma Patients. J Clin Lab Anal 2017;31. [PMID: 27616735 DOI: 10.1002/jcla.22028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Schaller G, Brix JM, Placher-sorko G, Höllerl F, Schernthaner G, Schernthaner G. YKL-40 concentrations are not elevated in gestational diabetes. European Journal of Clinical Investigation 2010;40:339-43. [DOI: 10.1111/j.1365-2362.2010.02274.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
15 Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Iwata Y, Tsuchiya KJ, Sugihara G, Kikuchi M, Okazaki Y, Yoshikawa T. Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations. Am J Med Genet 2009;150B:508-14. [DOI: 10.1002/ajmg.b.30847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
16 Huang K, Wu LD. YKL-40: a potential biomarker for osteoarthritis. J Int Med Res 2009;37:18-24. [PMID: 19215669 DOI: 10.1177/147323000903700102] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
17 Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis. Cell Mol Life Sci 2019;76:1833-63. [PMID: 30770953 DOI: 10.1007/s00018-019-03040-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
18 Qi R, Jin X, Shi H, Wang C, Li H, Shi X. Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension. Annals of Hepatology 2019;18:898-901. [DOI: 10.1016/j.aohep.2019.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009;511:159-84. [PMID: 19347297 DOI: 10.1007/978-1-59745-447-6_7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
20 Wu I, Kao P, Huang Y, Ding S. In vitro and in vivo osteogenesis of gelatin-modified calcium silicate cement with washout resistance. Materials Science and Engineering: C 2020;117:111297. [DOI: 10.1016/j.msec.2020.111297] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
21 Kjaergaard AD, Johansen JS, Nordestgaard BG, Bojesen SE. Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population. J Med Genet 2013;50:831-7. [PMID: 24062521 DOI: 10.1136/jmedgenet-2013-101908] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
22 Hansen M, Nielsen AR, Vilsbøll T, Lund A, Krarup T, Knop FK, Vestergaard H. Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes. Pancreas. 2012;41:1316-1318. [PMID: 22647735 DOI: 10.1097/mpa.0b013e31824d9b93] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
23 Stawerski P, Wągrowska-Danilewicz M, Stasikowska-Kanicka O, Danilewicz M. Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers. Pathol Res Pract 2011;207:573-6. [PMID: 21820815 DOI: 10.1016/j.prp.2011.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
24 Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, Eriksson C. Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling. Cellular Signalling 2013;25:1567-73. [DOI: 10.1016/j.cellsig.2013.03.016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
25 Ripoll E, Arribas I, Relea P, Varela L, Villa LF, Revilla M, Rico H. Beta-2-microglobulin in diseases with high bone remodeling. Calcif Tissue Int 1995;57:272-6. [DOI: 10.1007/bf00298882] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
26 Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 Like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:201. [PMID: 32929074 DOI: 10.1038/s41392-020-00303-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
27 Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol. 2008;26:47-52. [PMID: 18190830 DOI: 10.1016/j.urolonc.2007.07.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wong MM, Rao LG, Ly H, Hamilton L, Ish-shalom S, Sturtridge W, Tong J, Mcbroom R, Josse RG, Murray TM. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls [1]. Osteoporosis Int 1994;4:21-31. [DOI: 10.1007/bf02352257] [Cited by in Crossref: 38] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
29 Ahn SS, Yoon T, Park YB, Prendecki M, Bhangal G, McAdoo SP, Lee SW. Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study. Arthritis Res Ther 2021;23:77. [PMID: 33685523 DOI: 10.1186/s13075-021-02467-1] [Reference Citation Analysis]
30 Manduca P, Palermo C, Caruso C, Brizzolara A, Sanguineti C, Filanti C, Zicca A. Rat tibial osteoblasts III: propagation in vitro is accompanied by enhancement of osteoblast phenotype. Bone 1997;21:31-9. [PMID: 9213005 DOI: 10.1016/s8756-3282(97)00037-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Mylin AK, Abildgaard N, Johansen JS, Andersen NF, Heickendorff L, Standal T, Gimsing P, Knudsen LM. High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients. Eur J Haematol 2008;80:310-7. [DOI: 10.1111/j.1600-0609.2007.01027.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
32 Johansen JS, Christoffersen P, Møller S, Price PA, Henriksen JH, Garbarsch C, Bendtsen F. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol. 2000;32:911-920. [PMID: 10898311 DOI: 10.1016/s0168-8278(00)80095-1] [Cited by in Crossref: 172] [Cited by in F6Publishing: 74] [Article Influence: 7.8] [Reference Citation Analysis]
33 Roslind A, Johansen JS, Christensen IJ, Kiss K, Balslev E, Nielsen DL, Bentzen J, Price PA, Andersen E. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int J Cancer. 2008;122:857-863. [PMID: 17957792 DOI: 10.1002/ijc.23152] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
34 Erzin Y, Uzun H, Karatas A, Celik AF. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn’s disease. J Gastroenterol Hepatol. 2008;23:e357-e362. [PMID: 17725598 DOI: 10.1111/j.1440-1746.2007.05121.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
35 Xing S, Zheng X, Zeng T, Zeng MS, Zhong Q, Cao YS, Pan KL, Wei C, Hou F, Liu WL. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World J Gastroenterol 2017; 23(43): 7693-7704 [PMID: 29209110 DOI: 10.3748/wjg.v23.i43.7693] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
36 Takaishi S, Wang TC. Gene expression profiling in a mouse model of Helicobacter-induced gastric cancer. Cancer Sci 2007;98:284-93. [PMID: 17270017 DOI: 10.1111/j.1349-7006.2007.00392.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
37 Thapa N, Kang K, Kim I. βig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone 2005;36:232-42. [DOI: 10.1016/j.bone.2004.08.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
38 Mediero A, Cronstein BN. Adenosine and bone metabolism. Trends Endocrinol Metab 2013;24:290-300. [PMID: 23499155 DOI: 10.1016/j.tem.2013.02.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
39 Brøchner CB, Johansen JS, Larsen LA, Bak M, Mikkelsen HB, Byskov AG, Andersen CY, Møllgård K. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers. J Histochem Cytochem 2012;60:188-204. [PMID: 22140133 DOI: 10.1369/0022155411433331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
40 Schmidt H, Johansen JS, Sjoegren P, Christensen IJ, Sorensen BS, Fode K, Larsen J, von der Maase H. Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma. JCO 2006;24:798-804. [DOI: 10.1200/jco.2005.03.7960] [Cited by in Crossref: 57] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
41 Ankersen L, Kassem M, Østergaard L, Eriksen E, Clark B, Rattan S. Aging of human trabecular osteoblasts in culture. Archives of Gerontology and Geriatrics 1994;19:5-12. [DOI: 10.1016/s0167-4943(05)80042-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacology & Therapeutics 1993;59:329-41. [DOI: 10.1016/0163-7258(93)90074-n] [Cited by in Crossref: 173] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
43 ter Brugge PJ, Wolke JGC, Jansen JA. Effect of calcium phosphate coating crystallinity and implant surface roughness on differentiation of rat bone marrow cells. J Biomed Mater Res 2002;60:70-8. [DOI: 10.1002/jbm.10031] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
44 Johansen JS, Cintin C, Jørgensen M, Kamby C, Price PA. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer. 1995;31A:1437-1442. [PMID: 7577068 DOI: 10.1016/0959-8049(95)00196-p] [Cited by in Crossref: 91] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
45 Zheng M, Cai WM, Zhao JK, Zhu SM, Liu RH. Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Trop. 2005;96:148-152. [PMID: 16188216 DOI: 10.1016/j.actatropica.2005.07.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
46 Mylin AK, Abildgaard N, Johansen JS, Heickendorff L, Kreiner S, Waage A, Turesson I, Gimsing P; Nordic Myeloma Study Group. Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma. Leuk Lymphoma 2015;56:2650-9. [PMID: 25573204 DOI: 10.3109/10428194.2015.1004168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
47 Montjovent MO, Bocelli-Tyndall C, Scaletta C, Scherberich A, Mark S, Martin I, Applegate LA, Pioletti DP. In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications. Tissue Eng Part A 2009;15:1523-32. [PMID: 19196143 DOI: 10.1089/ten.tea.2008.0222] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
48 Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Serum YKL-40 and colorectal cancer. Br J Cancer. 1999;79:1494-1499. [PMID: 10188896 DOI: 10.1038/sj.bjc.6690238] [Cited by in Crossref: 117] [Cited by in F6Publishing: 117] [Article Influence: 5.1] [Reference Citation Analysis]
49 Kawada M, Chen CC, Arihiro A, Nagatani K, Watanabe T, Mizoguchi E. Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein. Lab Invest. 2008;88:883-895. [PMID: 18490894 DOI: 10.1038/labinvest.2008.47] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
50 Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009;28:4456-4468. [PMID: 19767768 DOI: 10.1038/onc.2009.292] [Cited by in Crossref: 168] [Cited by in F6Publishing: 178] [Article Influence: 12.9] [Reference Citation Analysis]
51 Loukopoulos P, O'brien T, Ghoddusi M, Mungall B, Robinson W. Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Research in Veterinary Science 2004;77:131-41. [DOI: 10.1016/j.rvsc.2004.01.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
52 Hughes FJ, Aubin JE. Culture of cells of the osteoblast lineage. In: Arnett TR, Henderson B, editors. Methods in Bone Biology. Boston: Springer US; 1997. pp. 1-49. [DOI: 10.1007/978-0-585-38227-2_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
53 Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? Respir Med. 2005;99:396-402. [PMID: 15763444 DOI: 10.1016/j.rmed.2004.09.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
54 Liu K, Jin M, Ye S, Yan S. CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53. J Clin Lab Anal 2020;34:e23026. [PMID: 31536166 DOI: 10.1002/jcla.23026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
55 Ripoll E, Revilla M, Hernández ER, Arribas I, Villa LF, Rico H. New evidence that serum β 2 -microglobulin behaves as a biological marker of bone remodelling in women. Eur J Clin Invest 1996;26:681-5. [DOI: 10.1111/j.1365-2362.1996.tb02153.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
56 Noda Y, Kawaguchi T, Korenaga M, Yoshio S, Komukai S, Nakano M, Niizeki T, Koga H, Kawaguchi A, Kanto T, Torimura T. High serum interleukin-34 level is a predictor of poor prognosis in patients with non-viral hepatocellular carcinoma. Hepatol Res 2019;49:1046-53. [PMID: 30993774 DOI: 10.1111/hepr.13350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
57 Kim HH, Chung MH, Bin JH, Cho KS, Lee J, Suh JS. Urinary YKL-40 as a Candidate Biomarker for Febrile Urinary Tract Infection in Young Children. Ann Lab Med 2018;38:39-45. [PMID: 29071817 DOI: 10.3343/alm.2018.38.1.39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Manduca P, Sanguineti C, Pistone M, Boccignone E, Sanguineti F, Santolini F, Federici A. Differential expression of alkaline phosphatase in clones of human osteoblast-like cells. J Bone Miner Res 1993;8:291-300. [PMID: 8456585 DOI: 10.1002/jbmr.5650080306] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
59 Olsson B, Zetterberg H, Hampel H, Blennow K. Biomarker-based dissection of neurodegenerative diseases. Prog Neurobiol 2011;95:520-34. [PMID: 21524681 DOI: 10.1016/j.pneurobio.2011.04.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
60 Kim SH, Das K, Noreen S, Coffman F, Hameed M. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J Surg Oncol 2007;5:17. [PMID: 17286869 DOI: 10.1186/1477-7819-5-17] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
61 Yang B, Feng X, Liu H, Tong R, Wu J, Li C, Yu H, Chen Y, Cheng Q, Chen J, Cai X, Wu W, Lu Y, Hu J, Liang K, Lv Z, Zheng S. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma. Oncogene. 2020;39:6529-6543. [PMID: 32917956 DOI: 10.1038/s41388-020-01450-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
62 Ringsholt M, Høgdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007;38:33-43. [PMID: 17242979 DOI: 10.1007/s10735-006-9075-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
63 Yang S, Wu T, Tsai H, Lin L, Wang P. New markers in pelvic inflammatory disease. Clinica Chimica Acta 2014;431:118-24. [DOI: 10.1016/j.cca.2014.02.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
64 Mylin AK, Rasmussen T, Johansen JS, Knudsen LM, Nørgaard PH, Lenhoff S, Dahl IM, Johnsen HE. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur J Haematol. 2006;77:416-424. [PMID: 16930142 DOI: 10.1111/j.0902-4441.2006.t01-1-ejh2879.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
65 Suh J, Kim S, Cho KS, Jung I, Cho WK, Jeon YJ, Jung MH, Suh BK. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes. Pediatr Nephrol 2016;31:623-31. [DOI: 10.1007/s00467-015-3253-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Guo W, Wang J, Wei H. Serum YKL-40 Level Positively Correlates With Uterine Leiomyomas. Reprod Sci 2016;23:1559-64. [DOI: 10.1177/1933719116648219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
67 Price PA, Rice JS, Williamson MK. Conserved phosphorylation of serines in the Ser-X-Glu/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human. Protein Sci 1994;3:822-30. [PMID: 8061611 DOI: 10.1002/pro.5560030511] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 2.6] [Reference Citation Analysis]
68 Nielsen KR, Steffensen R, Boegsted M, Baech J, Lundbye-Christensen S, Hetland ML, Krintel SB, Johnsen HE, Nyegaard M, Johansen JS. Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects. Arthritis Res Ther 2011;13:R109. [PMID: 21714862 DOI: 10.1186/ar3391] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
69 Vignon É. Is glycoprotein YKL40 a new marker for joint disorders? Joint Bone Spine 2001;68:454-6. [DOI: 10.1016/s1297-319x(01)00307-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Kaynar MY, Tanriverdi T, Kafadar AM, Kacira T, Yurdakul F, Uzun H, Gumustas K. YKL-40 levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: preliminary results. J Clin Neurosci 2005;12:754-7. [PMID: 16153848 DOI: 10.1016/j.jocn.2005.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
71 Kasperk C, Schneider U, Sommer U, Niethard F, Ziegler R. Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro. Calcif Tissue Int 1995;57:120-6. [DOI: 10.1007/bf00298432] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
72 Kyrgios I, Galli-Tsinopoulou A, Stylianou C. Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children. Regul Pept 2013;183:69-73. [PMID: 23501042 DOI: 10.1016/j.regpep.2013.03.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
73 Broulik P, Štěpán J, Haas T. Beta 2-microglobulin does not behave as a biological marker of bone remodelling in patients with primary hyperparathyroidism. Clinica Chimica Acta 1998;278:61-6. [DOI: 10.1016/s0009-8981(98)00134-x] [Reference Citation Analysis]
74 Wang D, Lu JG, Wang Q, Du XL, Dong R, Wang P, Zhao L, Jiang X, Yuan LJ. Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension. Braz J Med Biol Res 2012;45:264-72. [PMID: 22267006 DOI: 10.1590/s0100-879x2012007500010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
75 Miyatake K, Tsuji K, Yamaga M, Yamada J, Matsukura Y, Abula K, Sekiya I, Muneta T. Human YKL39 (chitinase 3-like protein 2), an osteoarthritis-associated gene, enhances proliferation and type II collagen expression in ATDC5 cells. Biochem Biophys Res Commun 2013;431:52-7. [PMID: 23291184 DOI: 10.1016/j.bbrc.2012.12.094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
76 Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med. 2008;358:1682-1691. [PMID: 18403759 DOI: 10.1056/nejmoa0708801] [Cited by in Crossref: 350] [Cited by in F6Publishing: 211] [Article Influence: 25.0] [Reference Citation Analysis]
77 Zheng M, Wu YJ, Cai WM, Weng HL, Liu RH. Construction of a hepatic stellate cells subtracted cDNA library of differentially expressed genes in normal mice and mice with Schistosomiasis japonica. J Zhejiang Univ Sci B 2005;6:280-7. [PMID: 15754426 DOI: 10.1631/jzus.2005.B0280] [Reference Citation Analysis]
78 Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003;80:15-21. [PMID: 12889595 DOI: 10.1023/A:1024431000710] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
79 Grosso LT, Iha DK, Niu J, Wakabayashi RC, Johnson PW. Protease Profiles of Cells Isolated From Regenerative Membranes Are Associated With Clinical Outcomes. Journal of Periodontology 1997;68:809-18. [DOI: 10.1902/jop.1997.68.9.809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
80 Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223-231. [PMID: 15829322 DOI: 10.1016/j.lungcan.2004.11.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
81 Wang Y, Wong CW, Yan M, Li L, Liu T, Or PM, Tsui SK, Waye MM, Chan AM. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma. Cancer Lett 2018;429:54-65. [PMID: 29729901 DOI: 10.1016/j.canlet.2018.04.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
82 Fan JT, Si XH, Liao Y, Shen P. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer. Arch Gynecol Obstet 2013;287:111-5. [PMID: 22945838 DOI: 10.1007/s00404-012-2546-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
83 Salvatore V, Teti G, Bolzani S, Focaroli S, Durante S, Mazzotti MC, Falconi M. Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system. Cancer Cell Int 2014;14:40. [PMID: 24883044 DOI: 10.1186/1475-2867-14-40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
84 Zou L, He X, Zhang JW. The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Braz J Med Biol Res 2010;43:1232-8. [PMID: 21103788 DOI: 10.1590/s0100-879x2010007500133] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
85 Temel Yüksel İ, Aslan Çetin B, Köroğlu N, Aydoğan Mathyk B, Erdem B. Inflammatory marker YKL-40 levels in intrahepatic cholestasis of pregnancy. Gynecol Endocrinol 2019;35:635-7. [PMID: 30688121 DOI: 10.1080/09513590.2018.1563889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
86 De Ceuninck F, Pastoureau P, Bouet F, Bonnet J, Vanhoutte PM. Purification of guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes. J Cell Biochem 1998;69:414-24. [PMID: 9620168 DOI: 10.1002/(sici)1097-4644(19980615)69:4<414::aid-jcb3>3.0.co;2-q] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
87 Stringa E, Filanti C, Giunciuglio D, Albini A, Manduca P. Osteoblastic cells from rat long bone. I. Characterization of their differentiation in culture. Bone 1995;16:663-70. [DOI: 10.1016/8756-3282(95)00100-r] [Cited by in Crossref: 38] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
88 Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-13. [PMID: 8182141 DOI: 10.1172/JCI117205] [Cited by in Crossref: 341] [Cited by in F6Publishing: 87] [Article Influence: 12.2] [Reference Citation Analysis]
89 Kruit A, Grutters JC, Ruven HJ, van Moorsel CC, van den Bosch JM. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respiratory Medicine 2007;101:1563-71. [DOI: 10.1016/j.rmed.2006.12.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
90 Mansell J, Cooke M, Read M, Rudd H, Shiel A, Wilkins K, Manso M. Chitinase 3-like 1 expression by human (MG63) osteoblasts in response to lysophosphatidic acid and 1,25-dihydroxyvitamin D3. Biochimie 2016;128-129:193-200. [DOI: 10.1016/j.biochi.2016.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
91 Lecanda F, Avioli LV, Cheng S. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 1997;67:386-98. [DOI: 10.1002/(sici)1097-4644(19971201)67:3<386::aid-jcb10>3.0.co;2-b] [Cited by in Crossref: 199] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
92 Javath Hussain S, Selvaraj J, Mohanty Mohapatra M, Rajendiran S. Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion. Curr Probl Cancer 2019;43:354-62. [PMID: 30471784 DOI: 10.1016/j.currproblcancer.2018.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
93 Jin T, He P, Yang R, Geng R, Yang G, Xu Y. CHI3L1 promotes Staphylococcus aureus-induced osteomyelitis by activating p38/MAPK and Smad signaling pathways. Exp Cell Res 2021;403:112596. [PMID: 33826950 DOI: 10.1016/j.yexcr.2021.112596] [Reference Citation Analysis]
94 Conrozier T, Carlier MC, Mathieu P, Colson F, Debard AL, Richard S, Favret H, Bienvenu J, Vignon E. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 2000;59:828-31. [PMID: 11005786 DOI: 10.1136/ard.59.10.828] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
95 Abd El-Fattah AA, Sadik NAH, Shaker OG, Mohamed Kamal A. Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk. Mediators Inflamm 2018;2018:9853192. [PMID: 30498395 DOI: 10.1155/2018/9853192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
96 Tsuji T, Matsuyama Y, Natsume N, Hasegawa Y, Kondo S, Kawakami H, Yoshihara H, Iwata H. Analysis of Chondrex (YKL-40, HC gp-39) in the Cerebrospinal Fluid of Patients With Spine Disease: . Spine 2002;27:732-5. [DOI: 10.1097/00007632-200204010-00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
97 Mohanty AK, Singh G, Paramasivam M, Saravanan K, Jabeen T, Sharma S, Yadav S, Kaur P, Kumar P, Srinivasan A, Singh TP. Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution. J Biol Chem 2003;278:14451-60. [PMID: 12529329 DOI: 10.1074/jbc.M208967200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
98 Bi J, Lau SH, Lv ZL, Xie D, Li W, Lai YR, Zhong JM, Wu HQ, Su Q, He YL. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer. Hum Pathol. 2009;40:1790-1797. [PMID: 19765801 DOI: 10.1016/j.humpath.2009.07.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
99 Johansen JS, Jensen BV, Roslind A, Price PA. Is YKL-40 a new therapeutic target in cancer? Expert Opinion on Therapeutic Targets 2007;11:219-34. [DOI: 10.1517/14728222.11.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
100 Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. Journal of Biological Chemistry 1993;268:25803-10. [DOI: 10.1016/s0021-9258(19)74461-5] [Cited by in Crossref: 225] [Article Influence: 7.8] [Reference Citation Analysis]
101 Xu X, Ma H, Xu J, Huang H, Wu X, Xiong Y, Zhan H, Huang F. Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease. Bosn J Basic Med Sci 2014;14:120-4. [PMID: 25172968 DOI: 10.17305/bjbms.2014.3.42] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
102 Kang EJ, Jung H, Woo OH, Park KH, Woo SU, Yang DS, Kim AR, Lee JB, Kim YH, Kim JS, Seo JH. YKL-40 expression could be a poor prognostic marker in the breast cancer tissue. Tumour Biol 2014;35:277-86. [PMID: 23918300 DOI: 10.1007/s13277-013-1036-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
103 Connor JR, Dodds RA, Emery JG, Kirkpatrick RB, Rosenberg M, Gowen M. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthritis Cartilage 2000;8:87-95. [PMID: 10772238 DOI: 10.1053/joca.1999.0276] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 1.9] [Reference Citation Analysis]
104 Volck B, Ostergaard K, Johansen JS, Garbarsch C, Price PA. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. Scand J Rheumatol 1999;28:171-9. [PMID: 10380840 DOI: 10.1080/03009749950154257] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 2.2] [Reference Citation Analysis]
105 Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008;45:531-562. [PMID: 19003601 DOI: 10.1080/10408360802334743] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
106 Xu Q, Chai SJ, Qian YY, Zhang M, Wang K. Breast regression protein-39 (BRP-39) promotes dendritic cell maturation in vitro and enhances Th2 inflammation in murine model of asthma. Acta Pharmacol Sin 2012;33:1525-32. [PMID: 23178461 DOI: 10.1038/aps.2012.154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
107 Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 2006;281:21082-95. [PMID: 16704970 DOI: 10.1074/jbc.M601153200] [Cited by in Crossref: 99] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
108 Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol 2007;15:371-81. [PMID: 18091378 DOI: 10.1097/01.pai.0000213146.77772.6a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
109 Tjäderhane L, Salo T, Larjava H, Larmas M, Overall CM. A novel organ culture method to study the function of human odontoblasts in vitro: gelatinase expression by odontoblasts is differentially regulated by TGF-beta1. J Dent Res 1998;77:1486-96. [PMID: 9663433 DOI: 10.1177/00220345980770070301] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis]
110 Shui C, Scutt AM. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1?,25-dihydroxyvitamin D3 and dexamethasone in vitro. J Cell Physiol 2002;193:164-72. [DOI: 10.1002/jcp.10157] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
111 Peng C, Peng J, Jiang L, You Q, Zheng J, Ning X. YKL-40 protein levels and clinical outcome of human endometrial cancer. J Int Med Res 2010;38:1448-57. [PMID: 20926018 DOI: 10.1177/147323001003800427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
112 De Loor J, Decruyenaere J, Demeyere K, Nuytinck L, Hoste EA, Meyer E. Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patients. Crit Care 2016;20:38. [PMID: 26864834 DOI: 10.1186/s13054-016-1192-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
113 Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2015;86:1240-7. [PMID: 25589779 DOI: 10.1136/jnnp-2014-309562] [Cited by in Crossref: 132] [Cited by in F6Publishing: 129] [Article Influence: 18.9] [Reference Citation Analysis]
114 Lei S, Zhang Y, Deng F, Liu M, Liu X, Zhou X, Deng H. Bone mineral density and five prominent candidate genes in Chinese men: associations, interaction effects and their implications. Maturitas 2005;51:199-206. [DOI: 10.1016/j.maturitas.2004.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
115 Falta MT, Fontenot AP, Rosloniec EF, Crawford F, Roark CL, Bill J, Marrack P, Kappler J, Kotzin BL. Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4(+) T cell response to a rheumatoid arthritis-associated antigen. Arthritis Rheum 2005;52:1885-96. [PMID: 15934080 DOI: 10.1002/art.21098] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
116 Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem 2007;55:1213-28. [PMID: 17712177 DOI: 10.1369/jhc.7A7245.2007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
117 Dupont J, Tanwar MK, Thaler HT, Fleisher M, Kauff N, Hensley ML, Sabbatini P, Anderson S, Aghajanian C, Holland EC, Spriggs DR. Early detection and prognosis of ovarian cancer using serum YKL-40. J Clin Oncol. 2004;22:3330-3339. [PMID: 15310777 DOI: 10.1200/jco.2004.09.112] [Cited by in Crossref: 97] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
118 Kastrup J. Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? Immunobiology 2012;217:483-91. [DOI: 10.1016/j.imbio.2011.04.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
119 Yan J, Shen P, Zheng J, Liu M. Clinical correlation between serum YKL-40 protein level and recurrence of non-muscle invasive bladder cancer. Ann Transl Med 2015;3:354. [PMID: 26807409 DOI: 10.3978/j.issn.2305-5839.2015.11.22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Ober C, Chupp GL. The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr Opin Allergy Clin Immunol 2009;9:401-8. [PMID: 19644363 DOI: 10.1097/ACI.0b013e3283306533] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
121 Oshima H, Miyazaki R, Ohe Y, Hayashi H, Kawamura K, Kikuyama S. Isolation and sequence of a novel amphibian pancreatic chitinase. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2002;132:381-8. [DOI: 10.1016/s1096-4959(02)00046-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
122 Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479-501. [PMID: 21054166 DOI: 10.1146/annurev-physiol-012110-142250] [Cited by in Crossref: 471] [Cited by in F6Publishing: 471] [Article Influence: 42.8] [Reference Citation Analysis]
123 Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 2020;131:110680. [PMID: 32861071 DOI: 10.1016/j.biopha.2020.110680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Tandler N, Mosch B, Pietzsch J. Protein and non-protein biomarkers in melanoma: a critical update. Amino Acids 2012;43:2203-30. [DOI: 10.1007/s00726-012-1409-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
125 Tuten A, Kucur M, Imamoglu M, Oncul M, Acikgoz AS, Sofiyeva N, Ozturk Z, Kaya B, Oral E. Serum YKL-40 levels are altered in endometriosis. Gynecol Endocrinol 2014;30:381-4. [PMID: 24533749 DOI: 10.3109/09513590.2014.887671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
126 Panagakos FS, Kumar S. Differentiation of human osteoblastic cells in culture: Modulation of proteases by extracellular matrix and tumor necrosis factor-alpha. Inflammation 1995;19:423-43. [DOI: 10.1007/bf01534577] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
127 Lind T, Birch MA, Mckie N. Purification of an insect derived recombinant human ADAMTS-1 reveals novel gelatin (type I collagen) degrading activities. Mol Cell Biochem 2006;281:95-102. [DOI: 10.1007/s11010-006-0637-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
128 Rodr�guez JP, Montecinos L, R�os S, Reyes P, Mart�nez J. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 2000;79:557-65. [DOI: 10.1002/1097-4644(20001215)79:4<557::aid-jcb40>3.0.co;2-h] [Cited by in Crossref: 138] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
129 Kostenuik PJ, Sanchez-Sweatman O, Orr FW, Singh G. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clin Exp Metastasis 1996;14:19-26. [PMID: 8521612 DOI: 10.1007/BF00157682] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
130 Hosoda K, Kanzaki S, Eguchi H, Kiyoki M, Yamaji T, Koshihara Y, Shiraki M, Seino Y. Secretion of osteocalcin and its propeptide from human osteoblastic cells: Dissociation of the secretory patterns of osteocalcin and its propeptide. J Bone Miner Res 1993;8:553-65. [DOI: 10.1002/jbmr.5650080506] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
131 Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, Ostergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage. 2001;9:203-214. [PMID: 11300743 DOI: 10.1053/joca.2000.0377] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 5.6] [Reference Citation Analysis]
132 Schmidt H, Johansen JS, Gehl J, Geertsen PF, Fode K, von der Maase H. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer. 2006;106:1130-1139. [PMID: 16456816 DOI: 10.1002/cncr.21678] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 5.4] [Reference Citation Analysis]
133 Boot RG, Blommaart EF, Swart E, Ghauharali-van der Vlugt K, Bijl N, Moe C, Place A, Aerts JM. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem. 2001;276:6770-6778. [PMID: 11085997 DOI: 10.1074/jbc.m009886200] [Cited by in Crossref: 357] [Cited by in F6Publishing: 131] [Article Influence: 16.2] [Reference Citation Analysis]
134 Komi DE, Kazemi T, Bussink AP. New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma. Curr Allergy Asthma Rep 2016;16:57. [PMID: 27438466 DOI: 10.1007/s11882-016-0637-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
135 Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen DL, Price PA, Balslev E. YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer. Breast Cancer Res Treat 2008;112:275-85. [PMID: 18157633 DOI: 10.1007/s10549-007-9870-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
136 Zhang W, Murao K, Zhang X, Matsumoto K, Diah S, Okada M, Miyake K, Kawai N, Fei Z, Tamiya T. Resveratrol represses YKL-40 expression in human glioma U87 cells. BMC Cancer. 2010;10:593. [PMID: 21029458 DOI: 10.1186/1471-2407-10-593] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
137 Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Science 2005;96:183-90. [DOI: 10.1111/j.1349-7006.2005.00026.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
138 Mathiasen AB, Henningsen KMA, Harutyunyan MJ, Mygind ND, Kastrup J. YKL-40: a new biomarker in cardiovascular disease? Biomarkers in Medicine 2010;4:591-600. [DOI: 10.2217/bmm.10.58] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
139 Rico H, Ripoll E, Revilla M, Relea P, Villa LF. ?2-Microglobulin in postmenopausal osteoporosis. Calcif Tissue Int 1993;53:78-80. [DOI: 10.1007/bf01321882] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
140 Deutschmann C, Roggenbuck D, Schierack P. The loss of tolerance to CHI3L1 – A putative role in inflammatory bowel disease? Clinical Immunology 2019;199:12-7. [DOI: 10.1016/j.clim.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
141 De Ceuninck F, Pastoureau P, Agnellet S, Bonnet J, Vanhoutte PM. Development of an enzyme-linked immunoassay for the quantification of YKL-40 (cartilage gp-39) in guinea pig serum using hen egg yolk antibodies. Journal of Immunological Methods 2001;252:153-61. [DOI: 10.1016/s0022-1759(01)00352-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
142 Kim PJ, Hong DG, Park JY, Cho YL, Park IS, Lee YS. Immunohistochemical expression of YKL-40 in peritoneal endometriosis. Gynecol Endocrinol 2010;26:58-62. [PMID: 19701838 DOI: 10.3109/09513590903184068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
143 Boussac M, Garin J. Calcium-dependent secretion in human neutrophils: A proteomic approach. Electrophoresis 2000;21:665-72. [DOI: 10.1002/(sici)1522-2683(20000201)21:3<665::aid-elps665>3.0.co;2-u] [Cited by in Crossref: 83] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
144 Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002;9:598-604. [PMID: 11986266 DOI: 10.1128/cdli.9.3.598-604.2002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 35] [Article Influence: 0.5] [Reference Citation Analysis]
145 Thorn AP, Daugaard S, Christensen LH, Christensen IJ, Petersen MM. YKL-40 protein in osteosarcoma tumor tissue. APMIS 2016;124:453-61. [PMID: 26988273 DOI: 10.1111/apm.12524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
146 Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011;10:742-51. [PMID: 21357475 DOI: 10.1158/1535-7163.MCT-10-0868] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 9.0] [Reference Citation Analysis]
147 Wakabayashi RC, Wong F, Richards DW, Johnson PW. Protease repertoires of cells adherent to membranes recovered after guided tissue regeneration. J Periodontal Res 1996;31:171-80. [DOI: 10.1111/j.1600-0765.1996.tb00481.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
148 Francescone R, Ngernyuang N, Yan W, Bentley B, Shao R. Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis. Oncogene 2014;33:2110-22. [PMID: 23665676 DOI: 10.1038/onc.2013.160] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
149 Pan JJ, Ge YS, Xu GL, Jia WD, Liu WF, Li JS, Liu WB. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2013;139:1043-1054. [PMID: 23525579 DOI: 10.1007/s00432-013-1415-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
150 Kayhan S, Gumus A, Cinarka H, Murat N, Yilmaz A, Bedir R, Sahin U. The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions. J Thorac Dis 2013;5:634-40. [PMID: 24255777 DOI: 10.3978/j.issn.2072-1439.2013.09.19] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
151 Bodine PV, Trailsmith M, Komm BS. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 1996;11:806-19. [PMID: 8725178 DOI: 10.1002/jbmr.5650110612] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 2.7] [Reference Citation Analysis]
152 Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol 2009;5:1065-82. [PMID: 19792974 DOI: 10.2217/fon.09.66] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 7.4] [Reference Citation Analysis]
153 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci 2016;53:396-408. [PMID: 27187575 DOI: 10.1080/10408363.2016.1190683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
154 Brasso K, Christensen IJ, Johansen JS, Teisner B, Garnero P, Price PA, Iversen P. Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate 2006;66:503-13. [DOI: 10.1002/pros.20311] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
155 Szymańska-Chabowska A, Juzwiszyn J, Jankowska-Polańska B, Tański W, Chabowski M. Chitinase 3-Like 1, Nestin, and Testin Proteins as Novel Biomarkers of Potential Clinical Use in Colorectal Cancer: A Review. Adv Exp Med Biol 2020;1279:1-8. [PMID: 32170669 DOI: 10.1007/5584_2020_506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Rani R, Singh V. Overexpression of YKL-40 (CHI3L1 gene) in patient fluids may be a potential predictive marker for early detection of comorbidity in non-communicable disease. Med Hypotheses 2020;143:110076. [PMID: 32721792 DOI: 10.1016/j.mehy.2020.110076] [Reference Citation Analysis]
157 Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286:15332-15343. [PMID: 21385870 DOI: 10.1074/jbc.m110.212514] [Cited by in Crossref: 142] [Cited by in F6Publishing: 94] [Article Influence: 12.9] [Reference Citation Analysis]
158 Ohi K, Hashimoto R, Yasuda Y, Yoshida T, Takahashi H, Iike N, Iwase M, Kamino K, Ishii R, Kazui H, Fukumoto M, Takamura H, Yamamori H, Azechi M, Ikezawa K, Tanimukai H, Tagami S, Morihara T, Okochi M, Yamada K, Numata S, Ikeda M, Tanaka T, Kudo T, Ueno S, Yoshikawa T, Ohmori T, Iwata N, Ozaki N, Takeda M. The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case–control study and meta-analysis. Schizophrenia Research 2010;116:126-32. [DOI: 10.1016/j.schres.2009.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
159 Yamamori H, Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Kasahara E, Sekiyama A, Umeda-Yano S, Okada T, Iwase M, Kazui H, Ito A, Takeda M. A promoter variant in the chitinase 3-like 1 gene is associated with serum YKL-40 level and personality trait. Neurosci Lett 2012;513:204-8. [PMID: 22366530 DOI: 10.1016/j.neulet.2012.02.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
160 Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem. 1996;271:19415-19420. [PMID: 8702629 DOI: 10.1074/jbc.271.32.19415] [Cited by in Crossref: 140] [Cited by in F6Publishing: 132] [Article Influence: 5.4] [Reference Citation Analysis]
161 Schultz NA, Johansen JS. YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Cancers (Basel) 2010;2:1453-91. [PMID: 24281168 DOI: 10.3390/cancers2031453] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
162 Kacira T, Hanimoglu H, Kucur M, Sanus GZ, Kafadar AM, Tanriverdi T, Kaynar MY. Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2008;15:1011-6. [PMID: 18280741 DOI: 10.1016/j.jocn.2006.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
163 Sobue T, Hakeda Y, Kobayashi Y, Hayakawa H, Yamashita K, Aoki T, Kumegawa M, Noguchi T, Hayakawa T. Tissue Inhibitor of Metalloproteinases 1 and 2 Directly Stimulate the Bone-Resorbing Activity of Isolated Mature Osteoclasts. J Bone Miner Res 2001;16:2205-14. [DOI: 10.1359/jbmr.2001.16.12.2205] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
164 Väänänen T, Koskinen A, Paukkeri EL, Hämäläinen M, Moilanen T, Moilanen E, Vuolteenaho K. YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints. Mediators Inflamm 2014;2014:215140. [PMID: 25132728 DOI: 10.1155/2014/215140] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
165 Wollheim FA. Serum markers of articular cartilage damage and repair. Rheum Dis Clin North Am 1999;25:417-32, viii. [PMID: 10356426 DOI: 10.1016/s0889-857x(05)70076-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
166 Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 2008;25:801-9. [PMID: 18670741 DOI: 10.1007/s12325-008-0082-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
167 Scully S, Yan W, Bentley B, Cao QJ, Shao R. Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One 2011;6:e25819. [PMID: 21991364 DOI: 10.1371/journal.pone.0025819] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]